Interleukin-1-induced IL-8 and IL-6 gene expression and production in human mesangial cells is differentially regulated by cAMP

Kidney International

Volumn 48, Issue 6, 1995, Pages 1767-1777

  Robson, Rachel L ^a   Westwick, John ^a   Brown, Zarin ^a  

^a UNIVERSITY OF BATH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; CHOLERA TOXIN; CYCLIC AMP; FORSKOLIN; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; ISOBUTYLMETHYLXANTHINE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE CONTROL; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL;

EID: 0028808124     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1995.475     Document Type: Article

References (51)

1. SCHLONDORFF D: The glomerular mesangial cell: An expanding role for a specialized pericyte. FASEB J 1:272-281, 1987
2. SEDOR J, KONIECZKOWSKI M, HUANG S, GRONICH J, NAKAZATO Y, GORDON G, KING C: Cytokines, mesangial cell activation and glomerular injury. Kidney Int 43(Suppl 39):S65-S70, 1993
3. FLOEGE J, JOHNSON RJ: Cytokines in renal inflammation. Curr Opin Nephrol Hypertens 2:449-457, 1993
4. BROWN Z, STRICTER RM, CHENSUE SW, CESKA M, LINDLEY I, NEILD GH, KUNKEL SL, WESTWICK J: Cytokine-activated human mesangial cells generate the neutrophil chemoattractant, interleukin 8. Kidney Int 40:86-90, 1991
5. BROWN Z, STRIETER RM, NEILD GH, THOMPSON RC, KUNKEL SL, WESTWICK J: Monocyte chemotactic peptide 1 generation by human mesangial cells: Modulation by an IL-1 receptor antagonist. Kidney Int 42:95-101, 1992
6. BROWN Z, FAIRBANKS LD, STRIETER RM, NEILD GH, KUNKEL SL, WESTWICK J: Human mesangial cell-derived interleukin 8 and interleukin 6: Modulation by an interleukin 1 receptor antagonist, in chemotactic cytokines-Biology of the inflammatory peptide supergene family. Adv Exp Biol Med 305:137-146, 1991
7. SAKLATVALA J, GUESDON F: Interleukin 1 and tumor necrosis factor signal transduction mechanisms: Potential targets for pharmacological control of inflammation. J Rheumatol 19:65-69, 1992
8. GUY GR, CHUA SP, WONG NS, NG SB, TAN YH: Interleukin 1 and tumor necrosis factor activate common multiple protein kinases in human fibroblasts. J Biol Chem 266:14343-14352, 1991
9. GUY GR, CAO X, CHUA SP, TAN YH: Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. J Biol Chem 267, 1846-1852, 1992
10. SEDOR J, NAKAZATO Y, KONIECZKOWSKI M: Interleukin-1 and the mesangial cell. Kidney Int 41:595-599, 1992
11. MIZEL SB: Cyclic AMP and interleukin 1 signal transduction. Immunol Today 11:390-391, 1990
12. O'NEILL LAJ, BIRD TA, SAKLATVALA J: Interleukin 1 signal transduction. Immunol Today 11:392-394, 1990
13. ZITNIK RJ, ZHENG T, ELIAS JA: cAMP inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts. Am J Physiol 264:L253-L260, 1993
14. SATRIANO JA, HORA K, SHAN Z, STANLEY ER, MORI T, SCHLONDORFF D: Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by IFN-τ, tumor necrosis factor-α, IgG aggregates, and cAMP in mouse mesangial cells. J Immunol 150:1971-1978, 1993
15. SEMMLER J, WACHTEL H, ENDRES S: The specific type IV phosphodiesterase inhibitor rolipram suppresses tumour necrosis factor-α production by human mononuclear cells. Int J Immunopharmacol 15:409-413, 1993
16. GILL DM, MEREN RA: ADP-ribosylation of membrane proteins catalysed by cholera toxin. Basis of the activation of adenylate cyclase. Proc Natl Acad Sci USA 75:3050, 1978
17. STERZEL RB, LOVETT DH, FOELLMER HG, PERFETTO MC, BIEMESDORFER D, KASHGARIAN M: Mesangial cell hillocks: Nodular foci of exaggerated growth of cells and matrix in prolonged culture. Am J Pathol 125:130-140, 1986
18. TAKTAK YS, SELKIRK S, BRISTOW AF, CARPENTER A, BALL C, RAFFERTY B, POOLE S: Assay of pyrogens by interleukin-6 release from monocytic cell lines. J Pharm Pharmacol 43:578-582, 1991
19. STRIETER R, PHAN S, SHOWELL H, REMICK D, LYNCH J, GENORD M, RAIFORD C, ESKANDARI M, MARKS R, KUNKEL S: Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J Biol Chem 264:10621-10626, 1989
20. O'NEILL LAJ, BIRD TA, GEARING AJ, SAKLATVALA J: Interleukin-1 signal transduction. Increased GTP binding and hydrolysis, in membranes of a murine thymoma line (EL4). J Biol Chem 265:3146-3152, 1990
21. BRADFORD MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
22. LAEMMLI UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
23. ROBISHAW JD, SMIGEL MD, GILMAN AG: Molecular basis for the two forms of G protein that stimulates Adenylate cyclase. J Biol Chem 261:9587-9590, 1986
24. POSTERNAK T, SUTHERLAND EW, HENLON WF: Derivatives; of 3′ 5′ adenosine monophosphate. Biochim Biophys Acta 65:558, 1962
25. SEAMAN KB, DALY JW: Forskolin: It's biological and chemical properties. Adv Cyclic Nucleotide Protein Phosphorylation Res 20:1-13, 1986
26. NICHOLSON DC, CHALLISS JRA, SHAHID M: Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. TIPS 12:19-27, 1991
27. 2 production is synergistically increased in cultured human glomerular mesangial cells by combinations of IL-1 and tumor necrosis factor-α. J Immunol 143:1989-1995, 1989
28. FRIEDLANDER G, CHANSEL J, SRAER J, BENS M, ARDAILLOU R: PGE2 binding sites and PG-stimulated cyclic AMP accumulation in rat isolated glomeruli and glomerular cultured cells. (abstract) Mol Cell Endocrinol 30:201, 1983
29. MEKALANOS JJ: Production and purification of cholera toxin. Meth Enzymol 165:169-175, 1988
30. GOUY H, DETERRE P, DEBRE P, BISMUTH G: Cell calcium signalling via G(M1) cell surface gangliosides in the human jurkat T cell line. J Immunol 152:3271-3281, 1994
31. 2+ in sensory neurons. J Neurosci Res 33:466-475, 1992
32. WOOGEN SD, TURO K, DIELEMAN LA, BEAGLEY KW, ELSON CO: Inhibition of murine T cell activation by cholera toxin B subunit is not mediated through the phosphatidylinositol second messenger system. J Immunol 150:3274-3283, 1993
33. IMBODEN JB, SHOBACK DM, PATTISON G, STOBO JD: Cholera toxin inhibits the T-cell antigen receptor-mediated increase in inositol trisphosphate and cytoplasmic free calcium. Proc Natl Acad Sci USA 83:5673-5677, 1986
34. QURESHI SA, ALEXANDROPOULOS K, JOSEPH CK, SPANGLER R, FOSTER DA: Cholera toxin induces expression of the immediate-early response gene JE via a cyclic AMP-independent signaling pathway. Mol Cell Biol 11:102-107, 1991
35. DENDORFER U, STROM TB, LIBERMANN TA: Multiple regulatory elements mediate interleukin-6 activation by prostaglandins and cyclic AMP. (abstract) J Cell Biochem 517A:105, 1993
36. AKIRA S, ISSHIK, H, SUGITA T, TANABE O, KINOSHITA S, NISHIO Y, NAKAJIMA T, HIRANO T, KISHIMOTO T: A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 9:1897-1906, 1990
37. KESSLER DJ, DUYAO MP, SPICER DB, SONENSHEIN GE: NF-κB-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts. J Exp Med 176:787-792, 1992
38. ZHANG Y, LIN J-L, VILCEK J: Synthesis of interleukin 6 (interferon-β2/B cell stimulatory factor-2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem 263:6177-6182, 1988
39. RAY A, TATTER SB, MAY LT, SEHGAL PB: Activation of the human "β2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists. Proc Natl Acad Sci USA 85:6701-6705, 1988
40. KREPS DM, WHITTLE SM, HOFFMAN JM, TOEWS ML: Lysophosphatidic acid mimics serum-induced sensitization of cyclic AMP accumulation. FASEB J 7:1376-1380, 1993
41. KASAHARA T, YAGISAWA H, YAMASHITA K, YAMAGUCHI Y, AKIYAMA Y: IL-1 induces proliferation and IL-6 mRNA expression in a human astrocytoma cell line: Positive and negative modulation by cholera toxin and cAMP. Biochem Biophys Res Commun 167:1242-1248, 1990
42. MCGEE DW, ELSON CO, MCGHEE JR: Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: Mode of action and augmenting effect of inflammatory cytokines. Infect Immun 61:4637-4644, 1993
43. GOSS JA, MANGINO MJ, GALLERY MP, FLYE MW: Prostaglandin E2 downregulates Kupffer cell production of IL-1 and IL-6 during hepatic regeneration. Am J Physiol 264:G601-G608, 1993
44. WAAGE A, SORENSEN M, STORDAL B: Differential effect of oxpentifylline on tumour necrosis factor and interleukin-6 production. Lancet 335:543, 1990
45. SCHLEGEL-HAUETER SE, AEBISCHER F: Cylic AMP modulates interleukin-1 action in a cytotoxic T-cell hybridoma. Cell Signal 2:489-496, 1990
46. KUNG AWC, LAU KS: Interleukin-1β modulates thyrotropin-induced thyroglobulin mRNA transcription through 3′,5′-cyclic adenosine monophosphate. Endocrinology 127:1369-1374, 1990
47. HURME M: Modulation of interleukin-1β production by cyclic AMP in human monocytes. FEBS Lett 263:35-37, 1990
48. RENZ H, GONG JH, SCHMIDT A, NAIN M, GEMSA D: Release of tumour necrosis factor-α from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 141:2388-2393, 1988
49. SMITH R, KASAHARA K, KUNKEL SL, KASAMA T, STRIETER RM: Potentiatiun of human neutrophil-derived interleukin-8 gene expression by cholera toxin, (abstract) FASEB J 6:A1895, 1992
50. PLEASS RD, WESTWICK J: Modulation of IL-8 generation in the pre-monocytic cell line, U937. In: Chemotactic cytokines - Biology of the inflammatory peptide supergene family, (abstract) Adv Exp Biol Med 305:J78, 1991
51. HORII Y, IWANO M, HIRATA E, SHIIKI H, FUJII Y, DOHI K, ISHIKAWA H: Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int 43(Suppl 39):S71-S75, 1993